Evolus Inc (STU:EVL)
€ 5.22 -0.28 (-5.13%) Market Cap: 344.66 Mil Enterprise Value: 445.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Q1 2025 Evolus Inc Earnings Call Transcript

May 07, 2025 / 08:30PM GMT
Release Date Price: €10.3 (+0.98%)

Key Points

Positve
  • Evolus Inc (EOLS) reported double-digit revenue growth in the first quarter, achieving a 15.5% increase over the prior year.
  • The company gained meaningful market share, outperforming the market and strengthening customer loyalty.
  • Evolus Inc (EOLS) successfully launched Evolysse Form and Evolysse Smooth, marking its transition into a multi-product company.
  • The company's loyalty program reached a new record with over 220,000 redemptions, indicating high consumer satisfaction and repeat usage.
  • Evolus Inc (EOLS) strengthened its financial position by refinancing its debt facility, reducing interest expenses, and increasing cash generation.
Negative
  • The company reduced its 2025 toxin market growth expectation to low-single-digits due to slower market growth.
  • Evolus Inc (EOLS) faced a challenging market backdrop with a decline in the toxin market in the first quarter.
  • The company's non-GAAP operating loss in the first quarter was $5.5 million, compared to $0.9 million in Q1 of 2024.
  • Evolysse is subject to a 10% tariff, expected to increase to 20%, impacting the company's cost structure.
  • The company experienced a decrease in cash, ending the first quarter with $67.9 million compared to $87 million at the end of the fourth quarter.
Operator

Good afternoon, everyone. Thank you for standing by. Welcome to Evolus' first-quarter earnings conference call.

As a reminder, today's conference is being recorded and webcast live. (Operator Instructions)

I would now like to turn the conference over to Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications.

Nareg Sagherian
Evolus Inc - Vice President, Head of Global Investor Relations and Corporate Communications

Thank you, operator. Welcome to everyone joining us on today's call to review Evolus' first-quarter financial results.

Our first-quarter press release is now on our website, at evolus.com.

With me, today, are David Moatazedi, President and Chief Executive Officer; and Sandra Beaver, Chief Financial Officer.

Today's call will include forward-looking statements. Actual results may differ, materially, due to risks and uncertainties outlined in our earnings press release and SEC filings. These forward-looking statements are based on current assumptions and we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot